{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:54:58Z","timestamp":1762005298982,"version":"3.44.0"},"reference-count":27,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,5]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>A 66-year-old man with pulmonary sarcoidosis was referred to the urology team for assessment of troublesome lower urinary tract symptoms. An elevated blood serum prostate-specific antigen raised concern for prostate cancer. An MRI of the prostate demonstrated a potentially aggressive prostate lesion, along with low T1 signal skeletal lesions, suggestive of metastatic disease. Subsequent bone scan and MRI whole spine demonstrated further skeletal lesions. In cases of known prostate cancer, sometimes a presumptive diagnosis of skeletal metastases is made without histological diagnosis from the skeletal lesions. However, there were certain factors in this case whereby skeletal biopsy was deemed prudent prior to further therapy. Factors included atypical MRI signal characteristics for metastatic disease, absence of a positive tissue diagnosis from the prostate and the clinical background of sarcoidosis. The biopsy confirmed skeletal sarcoid rather than metastatic disease, thereby avoiding inappropriate and potentially toxic treatment for the patient.<\/jats:p>","DOI":"10.1136\/bcr-2020-238493","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T12:20:13Z","timestamp":1617366013000},"page":"e238493","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Skeletal sarcoidosis; an uncommon mimic of metastatic disease"],"prefix":"10.1136","volume":"14","author":[{"given":"Matthew","family":"Sarvesvaran","sequence":"first","affiliation":[{"name":"Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthusamy","family":"Chandramohan","sequence":"additional","affiliation":[{"name":"Radiology, Bradford Royal Infirmary, Bradford, Yorkshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"2025082802301554000_14.4.e238493.1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Diagnosis, and treatment of sarcoidosis","volume":"3","author":"Ungprasert","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2025082802301554000_14.4.e238493.2","unstructured":"British Lung Foundation . Sarcoidosis statistics. Available: https:\/\/statistics.blf.org.uk\/sarcoidosis [Accessed 1st June 2020]."},{"key":"2025082802301554000_14.4.e238493.3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/kex317","article-title":"A review of the musculoskeletal manifestations of sarcoidosis","volume":"57","author":"Bechman","year":"2018","journal-title":"Rheumatology"},{"key":"2025082802301554000_14.4.e238493.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000158538.29753.b8"},{"key":"2025082802301554000_14.4.e238493.5","doi-asserted-by":"publisher","DOI":"10.1148\/rg.241035076"},{"key":"2025082802301554000_14.4.e238493.6","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3182335f9b"},{"key":"2025082802301554000_14.4.e238493.7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semarthrit.2017.02.004","article-title":"Clinical characteristics of patients with bone sarcoidosis","volume":"47","author":"Zhou","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2025082802301554000_14.4.e238493.8","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7498"},{"key":"2025082802301554000_14.4.e238493.9","unstructured":"Prostate cancer UK . The PSA test. Available: https:\/\/prostatecanceruk.org\/prostate-information\/prostate-tests\/psa-test [Accessed Nov 2016]."},{"key":"2025082802301554000_14.4.e238493.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"2025082802301554000_14.4.e238493.11","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"key":"2025082802301554000_14.4.e238493.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2940"},{"key":"2025082802301554000_14.4.e238493.13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0972-3919.183605","article-title":"Metastatic mimics on bone scan: \u201cAll that glitters is not metastatic\u201d","volume":"31","author":"Agrawal","year":"2016","journal-title":"Indian J Nucl Med"},{"key":"2025082802301554000_14.4.e238493.14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/0284186X.2015.1027411","article-title":"Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18F-NaF PET\/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial","volume":"55","author":"Jambor","year":"2016","journal-title":"Acta Oncol"},{"key":"2025082802301554000_14.4.e238493.15","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7420"},{"key":"2025082802301554000_14.4.e238493.16","doi-asserted-by":"publisher","DOI":"10.12659\/PJR.883628"},{"key":"2025082802301554000_14.4.e238493.17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jmri.1880070224","article-title":"Useful internal standards for distinguishing infiltrative marrow pathology from hematopoietic marrow at MRI","volume":"7","author":"Carroll","year":"1997","journal-title":"J Magn Reson Imaging"},{"key":"2025082802301554000_14.4.e238493.18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1148\/radiology.188.1.8511306","article-title":"Bull's-eyes and halos: useful Mr discriminators of osseous metastases","volume":"188","author":"Schweitzer","year":"1993","journal-title":"Radiology"},{"key":"2025082802301554000_14.4.e238493.19","doi-asserted-by":"crossref","first-page":"100213","DOI":"10.1016\/j.jbo.2018.100213","article-title":"The need for bone biopsies in the diagnosis of new bone lesions in patients with a known primary malignancy: a comparative review of 117 biopsy cases","volume":"14","author":"Zhang","year":"2019","journal-title":"J Bone Oncol"},{"key":"2025082802301554000_14.4.e238493.20","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.08.1882"},{"key":"2025082802301554000_14.4.e238493.21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2214\/AJR.12.10261","article-title":"Biopsy of suspicious bone lesions in patients with a single known malignancy: prevalence of a second malignancy","volume":"201","author":"Raphael","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"2025082802301554000_14.4.e238493.22","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.4934"},{"key":"2025082802301554000_14.4.e238493.23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.blo.0000229296.52216.77","article-title":"Importance of biopsy of new bone lesions in patients with previous carcinoma","volume":"451","author":"Clayer","year":"2006","journal-title":"Clin Orthop Relat Res"},{"key":"2025082802301554000_14.4.e238493.24","first-page":"463","article-title":"Clinical background and its relation to results of percutaneous needle biopsy of suspected bone metastasis under guidance with CT fluoroscopy","volume":"23","author":"Aoki","year":"2005","journal-title":"Radiat Med"},{"key":"2025082802301554000_14.4.e238493.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-014-0401-4"},{"key":"2025082802301554000_14.4.e238493.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2010.01.011"},{"key":"2025082802301554000_14.4.e238493.27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00270-017-1658-5","article-title":"CIRSE guidelines on percutaneous needle biopsy (pnb)","volume":"40","author":"Veltri","year":"2017","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-238493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:30:24Z","timestamp":1756373424000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-238493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,2]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-238493"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-238493","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}